Michael received his PhD in physiology from the Philipps University in Marburg, Germany. He has more than 25 years of experience in the pharmaceutical industry, starting in diabetes research for Lilly in 1994. After leading quality assurance for a manufacturing site and various project management responsibilities, he has spent most of his career in medical affairs, responsible for field medical teams, scientific exchange, research collaborations, medical communications, medical information, patient engagement, scientific training, and development, and scientific publications. Before joining MSD, he worked for 14 years at Amgen as the executive director and EU head of scientific affairs. Since February 2019, he has been the executive director of EMEAC medical and value capabilities for MSD based in Switzerland.